This site is intended for health professionals only
Saturday 21 April 2018
Share |

Latest News

New collaboration to engage patients in drug development for better health outcomes

Friday 20th April 2018

A new collaboration involving 34 public and private partners has been formed in an effort  to enable patients to be engaged in drug development and approval processes.

Paradigm- Patients active in research and dialogues for an improved generation of medicines - comprises a mix of partners from patient organisations, regulators, universities, not-for-profit...

Fri, 20 Apr 2018
Once-daily single inhaler triple therapy superior to Relvar, Ellipta and Anoro Ellipta across multiple endpoints including exacerbations, lung function and quality of life
Thu, 19 Apr 2018
Three studies shed light on cancer evolution and could lead to tests that give more accurate prognoses and personalised treatment
Thu, 19 Apr 2018
Novartis announces Aimovig™ could be an effective preventive treatment option for episodic migraine patients where previous treatments have failed
Thu, 19 Apr 2018
Europe’s national science and medical academies call for tailor-made interventions, European vaccination card and registry
Fri, 13 Apr 2018
Acquisition strengthens Orchard’s position as a global leader in gene therapy for rare diseases
Thu, 12 Apr 2018
Gene discovery could lead to future individualised therapy in myeloma, researchers find
Thu, 12 Apr 2018
The Scottish Medicines Consortium (SMC) has accepted Shire's Revestive® (teduglutide) for restricted use in children aged one and above with short bowel syndrome